Welcome to 2023 Stanford Drug Discovery Symposium. This symposium provides a valuable and important platform for inspiring interdisciplinary exchange at the forefront of drug research and will support a fantastic networking experience. It provides a great resource for researchers, pharmaceutical companies, investment groups, and those in the wider biomedical community interested in discovering new drugs and improving patient care. We look forward to an exciting two days of talks and discussion.
— Joseph C. Wu, MD, PhD | Director, Cardiovascular Institute
CEO, Altos Labs
CEO, American Heart Association
Chairman and CEO, Exact Sciences
CSO and President, Worldwide Research, Development and Medical, Pfizer
CEO, Alnylm Pharmaceuticals
Board of Directors: Gilead, Moderna, & Olema Pharma. Co-Founder and Advisor, EQRx
Executive Vice President of Research & Development, Cytokinetics
President, Novartis Institutes for BioMedical Research
Global Head of Research, Chief Scientific Officer, Sanofi
President, R&D, Takeda Pharmaceutical Company
CEO and Founder, Foresite Capital Management, LLC
Senior Vice President, Science & Technology, Alexandria Real Estate Equities
Chief Scientist, FDA
President & CEO, Leukemia & Lymphoma Society
Deputy Director for Clinical and Translational Research, National Cancer Institute
CMO and Head of Worldwide Medical & Safety, Pfizer
Chief Data Science Officer & Global Head, Strategy and Operations, R&D, The Janssen Pharmaceutical Companies of Johnson and Johnson
Executive Vice President, Pharmaceuticals, R&D, Johnson & Johnson
President and CEO, CIRM
Chairman and CEO, Gilead Sciences
Executive Vice President and CMP, Caris Life Sciences
President and Bing Presidential Professor
Stanford University
Chairman & CEO, Amgen
Director, Center for Drug Evaluation and Research, FDA
CEO Illumina
Executive VP, Head of Product Development, and Chief Medical Officer, Genentech/Roche
CEO, Genentech
Senior Vice President of Research, GlaxoSmithKline
Director, Center for Biologics Evaluation and Research (CBER), Food and Drug Administration (FDA)
Carl and Elizabeth Naumann Professorship for the Dean, Stanford School of Medicine
Chief Medical Officer, Gilead
Managing Partner, Walden Catalyst
Co-CEO, WuXi AppTec
Nobel Laureate 2022; Baker Family Director of Stanford ChEM-H
Nobel Laureate 1980; Robert W. and Vivian K. Cahill Professor of Research, Emeritus, Stanford University
Nobel Laureate 2020; Li Ka Shing Chancellor’s Chair Professor at UC Berkeley
Nobel Laureate 2006; Mrs. George A. Winzer Professor of Medicine, Stanford University
Nobel Laureate 2012; Helene Irwin Fagan Chair of Cardiology, Stanford University